1
EXHIBIT 10.19
[ALLOS THERAPEUTICS, INC. LOGO]
January 11, 2000
On March 25, 1999 representatives of Hovione, SA and Allos Therapeutics, Inc.
signed a term sheet indicating the intent of Hovione and Allos to establish a
supply agreement and its anticipated terms. According to this term sheet Hovione
would be the primary supplier of RSR13 sodium salt to Allos Therapeutics, during
clinical development and for a designated number of years after
commercialization. Since the signing of the term sheet Hovione and Allos
Therapeutics have worked together to develop RSR13 sodium salt.
This letter has two purposes: (1) To recognize that both parties still agree
that the terms in March 25, 1999 term sheet will form the basis of the
definitive contract and (2) that the terms contained in the term sheet will
function as a supply agreement until the definitive agreement is reached.
Acknowledged and Agreed
ALLOS THERAPEUTICS, INC. HOVIONE INTER LIMITED
By: /s/ Xxxxxxx X. Xxxxxxx, Ph.D., M.D. By: /s/ Chry Xxxxxx
------------------------------------ -------------------------
Xxxxxxx X. Xxxxxxx, Ph.D., M.D. Xxxx Xxxxxx
President & Chief Executive Officer Chief Executive Officer
Date: 1/12/00 Date: 13th January 2000
----------- ---------------------
CONFIDENTIAL-[HOVIONE LOGO] HOVIONE
0000 Xxxxx Xxxxxxxx, Xxxxx 000 - Xxxxxx, XX 00000 - 303/426-6262
Fax 303/000-0000
